AMENDMENT TO OFFER LETTEROffer Letter • January 31st, 2024 • bioAffinity Technologies, Inc. • Services-commercial physical & biological research • Texas
Contract Type FiledJanuary 31st, 2024 Company Industry JurisdictionThis Amendment (this “Amendment”), effective as of the 26th day of January 2024, to the Offer Letter, dated April 11, 2023 (the “Offer Letter”), by and between bioAffinity Technologies, Inc. (the “Company”) and Michael Dougherty (“Dougherty”). Capitalized terms used herein without definition shall have the meanings assigned in the Offer Letter.